Businesses adopting artificial intelligence and machine learning technologies and the companies developing them turn to us to navigate regulatory complexities, potential liabilities, and transactional considerations they face on the path to realizing AI’s tremendous potential.
We bring together our extensive technical backgrounds and broad range of subject matter experience to help them:
Our Digital Health lawyers are advising life sciences and healthcare companies as they adopt and develop AI tools and technologies in their businesses and in the products they deliver—from digital diagnostics to digital therapeutic medical devices to medical robotics.
King & Spalding offers deep fintech industry and AI credentials to provide comprehensive legal advice to emerging and established fintech businesses, financial services firms, and PE/VC investors.
Our lawyers are at the forefront of guiding start-ups and emerging growth companies who are developing generative AI platforms and applications and the investors in such technologies.
August 10, 2021
Equifax to Acquire Appriss Insights for $1.825 billion
July 15, 2021
HeartFlow To Go Public in SPAC Merger
April 6, 2021
Sidetrade acquires Amalto